Roles of sildenafil in enhancing drug sensitivity in cancer.
Roles of sildenafil in enhancing drug sensitivity in cancer.
复制标题
DOI:
10.1158/0008-5472.can-11-0375
复制
发表时间:
2011-06-01
期刊:
影响因子:
11.2
通讯作者:
Chen ZS
中科院分区:
文献类型:
--
作者:
Shi Z;Tiwari AK;Patel AS;Fu LW;Chen ZS
The phenomenon of multidrug resistance (MDR) has decreased the hope for successful cancer chemotherapy. The ATP-binding cassette (ABC) transporter super-family is the largest transmembrane family. The overexpression of ABC transporters is a major determinant of MDR in cancer cells both in vitro and in vivo. Unfortunately, until recently, most of the strategies used to surmount ABC transporter-mediated MDR have had limited success. An ideal modulator of MDR would be one that has a low liability to induce toxicity and alter the pharmacokinetic profile of antineoplastic drugs. Sildenafil (Viagra®), an inhibitor of cGMP-specific phosphodiesterase types 5 (PDE5) was found to significantly reverse ABC-transporters-mediated MDR. Our results indicated that sildenafil had differential inhibitory effects on ABC transporters; it significantly decreased the efflux activity of ABCB1 and ABCG2, but had no significant effects on ABCC1. Emerging evidence indicates that sildenafil and other PDE5 inhibitors may enhance the sensitivity of certain types of cancer to standard chemotherapeutic drugs.